Deutsche Bank’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Deutsche Bank’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-65,224	Closed	-$3.9M	–	4527
2020 Q2	$3.9M	Sell	65,224 -35,300	-35%	-$2.18M	﹤0.01%	1431
2020 Q1	$5.97M	Sell	100,524 -31,222	-24%	-$1.82M	0.01%	1155
2019 Q4	$7.22M	Buy	131,746 +122,282	+1,292%	+$4.57M	﹤0.01%	1242
2019 Q3	$264K	Sell	9,464 -7,284	-43%	-$267K	﹤0.01%	3026
2019 Q2	$554K	Buy	16,748 +9,498	+131%	+$297K	﹤0.01%	3222
2019 Q1	$244K	Sell	7,250 -284	-4%	-$9.03K	﹤0.01%	3890
2018 Q4	$204K	Buy	+7,534	New	+$194K	﹤0.01%	3868

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Deutsche Bank's PRNB Position: Q3 2020 in Review

Deutsche Bank sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 65,224 shares — an estimated $3.9M sold.

Deutsche Bank first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $7.22M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Deutsche Bank reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Deutsche Bank sold 65,224 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $3.9M.
Deutsche Bank first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Deutsche Bank's Principia Biopharma Inc. Common Stock position peaked at $7.22M in Q4 2019.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.